RU2671176C2 - Семиохимические композиции для ослабления социальных конфликтов у кошек - Google Patents
Семиохимические композиции для ослабления социальных конфликтов у кошек Download PDFInfo
- Publication number
- RU2671176C2 RU2671176C2 RU2016137669A RU2016137669A RU2671176C2 RU 2671176 C2 RU2671176 C2 RU 2671176C2 RU 2016137669 A RU2016137669 A RU 2016137669A RU 2016137669 A RU2016137669 A RU 2016137669A RU 2671176 C2 RU2671176 C2 RU 2671176C2
- Authority
- RU
- Russia
- Prior art keywords
- methyl
- cats
- semiochemical
- semiochemical composition
- salts
- Prior art date
Links
- 241000282326 Felis catus Species 0.000 title claims abstract description 176
- 239000000203 mixture Substances 0.000 title claims abstract description 121
- 239000003620 semiochemical Substances 0.000 title claims abstract description 97
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 claims abstract description 57
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 claims abstract description 56
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 claims abstract description 56
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 claims abstract description 54
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- SHWINQXIGSEZAP-UHFFFAOYSA-N dimethyl heptanedioate Chemical compound COC(=O)CCCCCC(=O)OC SHWINQXIGSEZAP-UHFFFAOYSA-N 0.000 claims abstract description 31
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 claims abstract description 28
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 claims abstract description 27
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 claims abstract description 27
- 229940073769 methyl oleate Drugs 0.000 claims abstract description 27
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 claims abstract description 26
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 claims abstract description 26
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 claims abstract description 26
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000126 substance Substances 0.000 claims abstract description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 16
- 229930195729 fatty acid Natural products 0.000 claims description 16
- 239000000194 fatty acid Substances 0.000 claims description 16
- 150000004665 fatty acids Chemical group 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 229930182558 Sterol Natural products 0.000 claims description 7
- 150000001298 alcohols Chemical class 0.000 claims description 7
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 150000002576 ketones Chemical class 0.000 claims description 7
- 235000003702 sterols Nutrition 0.000 claims description 7
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 5
- 230000003000 nontoxic effect Effects 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 150000003432 sterols Chemical class 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 239000006199 nebulizer Substances 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 229940054051 antipsychotic indole derivative Drugs 0.000 claims description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 3
- 150000002475 indoles Chemical class 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 230000003014 reinforcing effect Effects 0.000 claims description 3
- 229940031439 squalene Drugs 0.000 claims description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 3
- 230000002238 attenuated effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 241001465754 Metazoa Species 0.000 abstract description 12
- DRUKNYVQGHETPO-UHFFFAOYSA-N Nonanedioic acid dimethyl ester Natural products COC(=O)CCCCCCCC(=O)OC DRUKNYVQGHETPO-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 230000006978 adaptation Effects 0.000 abstract description 2
- RGCVYEOTYJCNOS-UHFFFAOYSA-N (4-cyano-2-methylphenyl)boronic acid Chemical compound CC1=CC(C#N)=CC=C1B(O)O RGCVYEOTYJCNOS-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 40
- 230000016571 aggressive behavior Effects 0.000 description 26
- 239000003016 pheromone Substances 0.000 description 22
- 239000000902 placebo Substances 0.000 description 21
- 229940068196 placebo Drugs 0.000 description 21
- 206010001488 Aggression Diseases 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 15
- 230000006399 behavior Effects 0.000 description 14
- 238000000540 analysis of variance Methods 0.000 description 11
- 241000282324 Felis Species 0.000 description 9
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 230000027939 micturition Effects 0.000 description 7
- -1 sterol derivative of methyl laurate Chemical class 0.000 description 7
- 238000000585 Mann–Whitney U test Methods 0.000 description 6
- 239000004165 Methyl ester of fatty acids Substances 0.000 description 6
- 208000012761 aggressive behavior Diseases 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 229940049918 linoleate Drugs 0.000 description 5
- WTTJVINHCBCLGX-NQLNTKRDSA-N methyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC WTTJVINHCBCLGX-NQLNTKRDSA-N 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- 239000000932 sedative agent Substances 0.000 description 5
- 230000001624 sedative effect Effects 0.000 description 5
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 4
- 229940070765 laurate Drugs 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 229940105132 myristate Drugs 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- 229940049964 oleate Drugs 0.000 description 4
- 229940114926 stearate Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 244000062645 predators Species 0.000 description 3
- 238000000528 statistical test Methods 0.000 description 3
- LJVNVNLFZQFJHU-UHFFFAOYSA-N 2-(2-phenylmethoxyethoxy)ethanol Chemical compound OCCOCCOCC1=CC=CC=C1 LJVNVNLFZQFJHU-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 238000001134 F-test Methods 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000011869 Shapiro-Wilk test Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000001558 permutation test Methods 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- NJTRAGRJFOWLGK-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethanol;2-methyloxirane Chemical compound CC1CO1.OCCOCCO NJTRAGRJFOWLGK-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- ZUAURMBNZUCEAF-UHFFFAOYSA-N 2-(2-phenoxyethoxy)ethanol Chemical compound OCCOCCOC1=CC=CC=C1 ZUAURMBNZUCEAF-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001455214 Acinonyx jubatus Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- YNDZLBYYUYXQED-UHFFFAOYSA-N CC=C.C(COCCO)O Chemical compound CC=C.C(COCCO)O YNDZLBYYUYXQED-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001455213 Leopardus pardalis Species 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000282374 Puma concolor Species 0.000 description 1
- 239000000877 Sex Attractant Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 210000003503 anal sac Anatomy 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 231100000871 behavioral problem Toxicity 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000031902 chemoattractant activity Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000037326 chronic stress Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002633 crown compound Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000011724 maternal aggressive behavior Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000011273 social behavior Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000020636 territorial aggressive behavior Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Anesthesiology (AREA)
- Environmental Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Agronomy & Crop Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461954785P | 2014-03-18 | 2014-03-18 | |
| US61/954785 | 2014-03-18 | ||
| PCT/IB2015/000633 WO2015140637A2 (en) | 2014-03-18 | 2015-03-17 | Semiochemical compositions to reduce social conflicts with cats |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016137669A RU2016137669A (ru) | 2018-04-20 |
| RU2016137669A3 RU2016137669A3 (enExample) | 2018-04-27 |
| RU2671176C2 true RU2671176C2 (ru) | 2018-10-29 |
Family
ID=53499035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016137669A RU2671176C2 (ru) | 2014-03-18 | 2015-03-17 | Семиохимические композиции для ослабления социальных конфликтов у кошек |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10258593B2 (enExample) |
| EP (1) | EP3119198B1 (enExample) |
| JP (1) | JP6814728B2 (enExample) |
| CN (1) | CN106456591B (enExample) |
| AU (1) | AU2015233073B2 (enExample) |
| BR (1) | BR112016021468B1 (enExample) |
| CA (1) | CA2943085C (enExample) |
| CL (1) | CL2016002362A1 (enExample) |
| DK (1) | DK3119198T3 (enExample) |
| ES (1) | ES2803076T3 (enExample) |
| HU (1) | HUE049993T2 (enExample) |
| LT (1) | LT3119198T (enExample) |
| MX (1) | MX390644B (enExample) |
| NZ (1) | NZ724712A (enExample) |
| PE (1) | PE20170072A1 (enExample) |
| PL (1) | PL3119198T3 (enExample) |
| PT (1) | PT3119198T (enExample) |
| RU (1) | RU2671176C2 (enExample) |
| SM (1) | SMT202000341T1 (enExample) |
| WO (1) | WO2015140637A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1023693B1 (nl) * | 2016-06-15 | 2017-06-16 | Vervaeke-Belavi Nv | Werkwijze voor het produceren van kuikens |
| CN110917241A (zh) * | 2019-12-13 | 2020-03-27 | 苏州弗艾柏生物科技有限公司 | 一种猫安抚信息素及其用途 |
| CN112516128A (zh) * | 2020-12-08 | 2021-03-19 | 上海弗艾柏生物科技有限公司 | 一种猫面部信息素及其应用 |
| FR3117731A1 (fr) * | 2020-12-21 | 2022-06-24 | Virbac | Dispositifs portables pour animaux de compagnie avec diffusion passive de compositions sémiochimiques |
| FR3119315B1 (fr) * | 2021-02-02 | 2022-12-30 | Virbac | « gel diffuseur de pheromones » |
| CN116763796B (zh) * | 2023-06-20 | 2024-07-05 | 咪咪聊(武汉)生物科技有限公司 | 一种猫用信息素及猫用信息素混合物的制备方法和应用 |
| WO2025210211A1 (en) * | 2024-04-05 | 2025-10-09 | Signs | Oil-in-water emulsion comprising a semiochemical composition, suitable for administration in the form of a mist |
| WO2025210210A1 (en) * | 2024-04-05 | 2025-10-09 | Signs | Oil-in-water emulsion comprising a semiochemical composition, suitable for administration in the form of a milk |
| WO2025210208A1 (en) * | 2024-04-05 | 2025-10-09 | Signs | Oil-in-water emulsion comprising a semiochemical composition, suitable for administration in the form of a cream |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996023414A1 (en) * | 1995-02-03 | 1996-08-08 | Patrick Pageat | Properties of cats' facial pheromones |
| WO1999037297A1 (en) * | 1998-01-21 | 1999-07-29 | Fideline | Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| US6054481A (en) * | 1998-01-21 | 2000-04-25 | Fideline | Pig appeasing pheromones for enhancing weight gain in a mammal |
| RU2360406C1 (ru) * | 2008-02-15 | 2009-07-10 | Леонид Геннадьевич Менчиков | Средство для борьбы с территориальными метками домашней кошки |
| WO2014001836A1 (en) * | 2012-06-25 | 2014-01-03 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Feline scratch marking semiochemicals |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60332635D1 (de) | 2002-06-19 | 2010-07-01 | Fideline Le Rieu Neuf | Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität |
| FR2931676B1 (fr) * | 2008-05-30 | 2011-01-14 | Ceva Sante Animale | Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains |
-
2015
- 2015-03-17 HU HUE15733524A patent/HUE049993T2/hu unknown
- 2015-03-17 SM SM20200341T patent/SMT202000341T1/it unknown
- 2015-03-17 MX MX2016012111A patent/MX390644B/es unknown
- 2015-03-17 CA CA2943085A patent/CA2943085C/en active Active
- 2015-03-17 LT LTEP15733524.1T patent/LT3119198T/lt unknown
- 2015-03-17 PT PT157335241T patent/PT3119198T/pt unknown
- 2015-03-17 RU RU2016137669A patent/RU2671176C2/ru active
- 2015-03-17 WO PCT/IB2015/000633 patent/WO2015140637A2/en not_active Ceased
- 2015-03-17 JP JP2017500455A patent/JP6814728B2/ja active Active
- 2015-03-17 EP EP15733524.1A patent/EP3119198B1/en active Active
- 2015-03-17 AU AU2015233073A patent/AU2015233073B2/en active Active
- 2015-03-17 PE PE2016001645A patent/PE20170072A1/es unknown
- 2015-03-17 PL PL15733524T patent/PL3119198T3/pl unknown
- 2015-03-17 ES ES15733524T patent/ES2803076T3/es active Active
- 2015-03-17 CN CN201580022207.1A patent/CN106456591B/zh active Active
- 2015-03-17 NZ NZ724712A patent/NZ724712A/en unknown
- 2015-03-17 DK DK15733524.1T patent/DK3119198T3/da active
- 2015-03-17 US US15/127,060 patent/US10258593B2/en active Active
- 2015-03-17 BR BR112016021468-4A patent/BR112016021468B1/pt active IP Right Grant
-
2016
- 2016-09-20 CL CL2016002362A patent/CL2016002362A1/es unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996023414A1 (en) * | 1995-02-03 | 1996-08-08 | Patrick Pageat | Properties of cats' facial pheromones |
| WO1999037297A1 (en) * | 1998-01-21 | 1999-07-29 | Fideline | Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| US6054481A (en) * | 1998-01-21 | 2000-04-25 | Fideline | Pig appeasing pheromones for enhancing weight gain in a mammal |
| RU2360406C1 (ru) * | 2008-02-15 | 2009-07-10 | Леонид Геннадьевич Менчиков | Средство для борьбы с территориальными метками домашней кошки |
| WO2014001836A1 (en) * | 2012-06-25 | 2014-01-03 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Feline scratch marking semiochemicals |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2943085A1 (en) | 2015-09-24 |
| JP6814728B2 (ja) | 2021-01-20 |
| CA2943085C (en) | 2022-12-13 |
| WO2015140637A2 (en) | 2015-09-24 |
| NZ724712A (en) | 2022-01-28 |
| HUE049993T2 (hu) | 2020-11-30 |
| BR112016021468B1 (pt) | 2020-12-08 |
| MX390644B (es) | 2025-03-21 |
| AU2015233073A1 (en) | 2016-10-20 |
| PE20170072A1 (es) | 2017-03-16 |
| PT3119198T (pt) | 2020-07-13 |
| CN106456591B (zh) | 2020-09-29 |
| CN106456591A (zh) | 2017-02-22 |
| MX2016012111A (es) | 2017-04-25 |
| WO2015140637A3 (en) | 2015-11-12 |
| US20180169053A1 (en) | 2018-06-21 |
| ES2803076T3 (es) | 2021-01-22 |
| AU2015233073B2 (en) | 2018-09-27 |
| SMT202000341T1 (it) | 2020-07-08 |
| BR112016021468A2 (pt) | 2017-08-15 |
| EP3119198B1 (en) | 2020-04-08 |
| RU2016137669A3 (enExample) | 2018-04-27 |
| CL2016002362A1 (es) | 2017-07-21 |
| LT3119198T (lt) | 2020-07-10 |
| EP3119198A2 (en) | 2017-01-25 |
| JP2017510634A (ja) | 2017-04-13 |
| DK3119198T3 (da) | 2020-07-13 |
| PL3119198T3 (pl) | 2020-10-05 |
| US10258593B2 (en) | 2019-04-16 |
| RU2016137669A (ru) | 2018-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2671176C2 (ru) | Семиохимические композиции для ослабления социальных конфликтов у кошек | |
| JP4750232B2 (ja) | ストレス、不安および攻撃性を低減するブタ鎮静フェロモン | |
| RU2671858C2 (ru) | Успокоительный феромон для кошек | |
| US9750691B2 (en) | Pheromone compositions and their use to modify behavior in different vertebrate species | |
| JP4783569B2 (ja) | クモ類を防除するためのアロモン忌避性およびカイロモン誘引性組成物 | |
| Ferkin et al. | Self‐grooming as a tactic used by prairie voles Microtus ochrogaster to enhance sexual communication | |
| JP2018507172A (ja) | 少なくとも１つの脂肪酸とネペタラクトンとを含む動物用鎮静組成物 | |
| Rooney et al. | Olfaction and Dog Welfare | |
| EP3328371B1 (en) | Pheromone compositions and uses thereof | |
| US9480688B2 (en) | Pheromone compositions and their use to modify behavior in different vertebrate species | |
| Bernachon et al. | Response to Acute Stress in Domestic Cats Using Synthetic Analogues of Natural Appeasing Pheromones with Nepeta cataria Extract Rich in Nepetalactone: A Double-blinded, Randomized, Positive Controlled Cross-over Study. | |
| JP4754688B2 (ja) | ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン | |
| Ibáñez et al. | Chemosensory assessment of rival body size is based on chemosignal concentration in male Spanish terrapins | |
| Madec et al. | Broilers (Gallus gallus) are less stressed if they can smell a mother odorant | |
| Fritz Jr | Self-enurination in the domesticated male goat (Capra hircus) | |
| Beck et al. | Case series: Efficacy of a formulation containing selamectin and sarolaner against naturally acquired mite infestations (Demodex sp., Ornithonyssus bacoti) in degus (Octodon degus) | |
| Pereira | Feliway® spray assessment to handle stress in cats in veterinary consultation | |
| Horwitz | Intercat aggression. | |
| Godwin et al. | Preponderances of dog owners to neutering of companion animals: A survey of dog owners in Maiduguri metropolis, Borno State, Nigeria | |
| Bakker | The use of Felifriend and Feliway spray for the clinical examination of cats | |
| Landsberg | Twenty years of evidence supporting pheromone therapy. | |
| Vlautin | The effect of contextual variables on intraspecific interactions and space-use in meadow voles, Microtus pennsylvanicus | |
| Song | The social behaviour of cats housed in laboratory cages: a thesis presented in partial fulfilment of the requirements for the degree of Masters of Science in Zoology at Massey University, Palmerston North, New Zealand | |
| Hall | Olfactory Communication in the Male Gray Short-tailed Opossum (Monodelphis Domestica) | |
| BR112016021430B1 (pt) | Composição tópica com feromônios para o tratamento de stress, ansiedade, agressividade e facilitação social para gatos |